Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan · Delayed Price · Currency is TWD

43.60

-0.30 (-0.68%)

Mar 6, 2026, 9:43 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Nutrition and Health Sector	1.65B	2.17B	2.40B	2.54B	3.33B
Nutrition and Health Sector Growth	-23.96%	-9.86%	-5.29%	-23.70%	-15.36%
Western Medicine Segment	2.74B	2.43B	2.33B	2.23B	2.06B
Western Medicine Segment Growth	13.12%	4.23%	4.38%	8.33%	-4.91%
Total	4.39B	4.59B	4.73B	4.77B	5.38B
Total Growth	-4.37%	-2.93%	-0.77%	-11.45%	-11.65%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	3.08B	2.88B	2.79B	2.70B	2.61B
Taiwan Growth	6.85%	3.57%	3.30%	3.13%	-8.62%
China	242.25M	701.54M	1.04B	1.23B	1.92B
China Growth	-65.47%	-32.24%	-15.51%	-36.16%	-16.11%
Southeast Asia	1.06B	992.73M	909.69M	845.25M	849.67M
Southeast Asia Growth	7.24%	9.13%	7.62%	-0.52%	-10.00%
Other	1.98M	12.74M	-	-	-
Other Growth	-84.48%	-	-	-	-
Total	4.39B	4.59B	4.73B	4.77B	5.38B
Total Growth	-4.37%	-2.93%	-0.77%	-11.45%	-11.65%

Source: S&P Global Market Intelligence.